Related Experiment Video
Updated: Aug 16, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease
Claudia Mandato1, Stefania Lucariello, Maria Rosario Licenziati
1Department of Pediatrics, European Laboratory for the Investigation of Food-Induced Diseases, University of Naples, Naples, Italy.
Insights
Pediatric obesity-related liver disease involves insulin resistance, oxidative stress, and inflammation. These factors are key to understanding and treating liver issues in obese children.
Area of Science:
- Pediatric Endocrinology
- Hepatology
- Metabolic Disorders
Background:
- Pediatric obesity is a growing health concern.
- Obesity is linked to various comorbidities, including liver disease.
- Non-alcoholic fatty liver disease (NAFLD) is a common manifestation in obese children.
Purpose of the Study:
- To investigate metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease.
- To differentiate these factors between obese children with and without liver abnormalities.
Main Methods:
- Study included 50 obese children (ages 7-14).
- Participants were divided into two groups: with (n=20) and without (n=30) hypertransaminasemia and ultrasonographic liver brightness.
- Assessed insulin resistance (fasting glucose/insulin ratio [FGIR]), leptin, iron, transferrin, ferritin, C-reactive protein (CRP), white blood cell (WBC) count, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, C282Y and H63D mutations, and erythrocytic glutathione peroxidase (GPX) activity.
Main Results:
- Group 1 (with liver issues) showed significantly higher FGIR, serum ferritin, CRP, and GPX activity compared to Group 2.
- FGIR, ferritin, and CRP were simultaneously abnormal in 41% of Group 1 patients.
- No significant differences were found in leptin, iron, transferrin, WBC, TNF-alpha, IL-6, or iron mutation status between the groups.
Conclusions:
- Insulin resistance, oxidative stress, and low-grade systemic inflammation are implicated in pediatric obesity-related liver disease.
- These pathophysiological mechanisms offer targets for therapeutic interventions.
- Findings support the development of targeted trials for hepatopathic obese children.
Objective:
To examine the role of metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease.
Study Design:
In 50 obese children (age 7 to 14 years) with (n = 20, group 1) or without (n = 30, group 2) hypertransaminasemia and ultrasonographic liver brightness, we studied insulin resistance (fasting glucose/insulin ratio [FGIR]) and serum levels of leptin, iron, transferrin, ferritin, C-reactive protein (CRP), white blood cell (WBC) count, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, C282Y and H63D mutations, and erythrocytic glutathione peroxidase (GPX) activity.
Results:
FGIR (6.7 +/- 4.1 vs 9.2 +/- 5.2; P = .02), serum ferritin (88.8 +/- 36.0 vs 39.9 +/- 24.0 ng/mL; P = .0001), serum CRP (5.4 +/- 6.0 vs 1.1 +/- 1.6 mg/dL; P = 0.004), and GPX (8.4 +/- 0.9 vs 5.0 +/- 0.5 U/g Hb; P = .05) were significantly higher and more frequently deranged in group 1 than in group 2. FGIR, ferritin, and CRP values were simultaneously deranged in 41% of the group 1 patients and in none of the group 2 patients ( P = .098). Serum leptin, iron, and transferrin, WBC, TNF-alpha, IL-6, and C282Y and H63D mutations were similar in the 2 groups.
Conclusions:
Insulin resistance, oxidative stress, and low-grade systemic inflammatory status are implicated in pediatric obesity-related liver disease. These findings may be useful in planning pathophysiologically based therapeutic trials for hepatopathic obese children who are unable to follow hypocaloric diets.
Related Concept Videos
Obesity
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Type II Diabetes I: Introduction
Cholecystitis
Peroxisomes
Pharmacokinetics in Pediatric Patients: Drug Metabolism
